Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Genetic variations in cancer patients may serve as important prognostic indicators of clinical outcome. The GNAS1 T393C single nucleotide polymorphism (SNP) diversely correlates with the clinical outcome in cancer. The aim of this study was to evaluate the potential prognostic value of T393C-SNP in complete resected only surgically treated esophageal cancer (EC).
Methods: Genomic DNA was extracted from peripheral blood leucocytes of 190 patients who underwent only complete surgical resection for EC. T393C-SNP was correlated with clinic-pathological parameters, tumor cell dissemination in bone marrow (DTC) and clinical outcome.
Results: T-allele carriers had more advanced disease due to presence of lymph node metastasis (P < 0.0001) and DTC (P = 0.01) and higher recurrence rate (P = 0.01) compared to CC genotype. The disease-free (P < 0.001) and overall survival (P < 0.001) was better in CC compared to TT and TC patients. In the multivariate Cox regression disease-stage adjusted analysis the T393C-SNP was identified as a strong independent prognostic factor for recurrence (hazard ratio 1.8, P = 0.01) and survival (hazard ratio 2.5, P < 0.001) in EC patients.
Conclusion: Determination of T393C-SNP preoperatively will allow allocation of EC patients into different risk profiles which may help to stratify patients eligible for neoadjuvant and or adjuvant therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s13402-011-0016-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Relationship between GNAS1 T393C polymorphism and aseptic loosening after total hip arthroplasty.
Eur J Med Res
August 2017
Institute of Pharmacogenetics, University Hospital Essen, 45147, Essen, Germany.
Background: Aseptic loosening is a main cause for revision surgery after total hip arthroplasty (THA) and there is no reliable marker for the early detection of patients at high risk. This study has been performed to validate association of the T393C polymorphism (rs7121) in the GNAS1 gene, encoding for the alpha-subunit of heterotrimeric G-protein Gs, with risk for and time to aseptic loosening after THA, which has been demonstrated in our previous study.
Methods: 231 patients with primary THA and 234 patients suffering from aseptic loosening were genotyped for dependency on GNAS1 genotypes and analyzed.
[Genetic dependency of blood pressure and heart rate in patients with arterial hypertension and obesity].
Vestn Ross Akad Med Nauk
February 2015
Background: The aim of the study was to determine the effect of gene polymorphisms Arg389Gly ADRβ1 gene and T393C gene GNAS1 on the level of heart rate (HR), systolic and diastolic blood pressure (SBP and DBP) in hypertensive patients according to body mass index (BMI).
Patients And Methods: The study involved 166 patients with hypertension and 90 healthy individuals. Patients of the main group was divided according to BMI into three subgroups: I subgroup--with normal body weight, II subgroup--overweight, II subgroup--obesity.
TT genotype of GNAS1 T393C polymorphism predicts better outcome of advanced non-small cell lung cancer patients.
World J Gastrointest Oncol
December 2014
Hong-Yun Gong, Wei-Guo Hu, Qin-Bin Song, Department of Oncology, Renmin Hospital of Wuhan University, Wuhan 430060, Hebei Province, China.
Article Synopsis
- The study aimed to assess the impact of the GNAS1 T393C polymorphism on prognosis in patients with advanced non-small cell lung cancer.
- Genomic DNA from 94 patients was analyzed, revealing that those with the TT genotype had a significantly longer median survival (25 months) compared to CT (12 months) and CC (8 months) genotypes.
- The findings suggested that the TT genotype is associated with better overall survival rates, highlighting the importance of genetic factors in predicting outcomes for lung cancer patients.
[Association between GNAS1 T393C polymorphism and therapeutic efficacy of tyrosine kinase inhibitor in pretreated advanced non-small cell lung cancer with unknown EGFR mutation status].
Zhongguo Fei Ai Za Zhi
April 2014
Zhejiang Cancer Hospital, Zhejiang Key Laboratory of the Diagnosis and Treatment Technology on Thoracic Oncology, Hangzhou 310022, China.
Background And Objective: Epidermal growth factor receptor (EGFR)-activating mutation predicts excellent response to EGFR tyrosine kinase inhibitors (TKIs). However, lung cancer patients are often with unknown EGFR mutation status because there are little tumor specimen to determine. TKIs induce tumor cell apoptosis which associates with several apoptosis-related genes.
View Article and Find Full Text PDFGαs protein expression is an independent predictor of recurrence in prostate cancer.
J Immunol Res
January 2015
Department of Medical Oncology, The First Affiliated Hospital, Xi'an Jiao Tong University of Medical College, Xi'an 710061, China.
Background: T393C polymorphism in the gene GNAS1, which encodes the G-protein alpha s subunit (Gαs) of heterotrimeric G protein, is significantly associated with the clinical outcome of patients suffering from several cancers. However, studies on the role and protein expression of Gαs subunit in prostate cancer were still unavailable.
Methods: The immunohistochemical staining was used to assess Gαs expression through tissue microarray procedure of 56 metastatic PCas, 291 localized PCas, and 67 benign hyperplasia (BPH).